Skip to main content
Top

VEXAS syndrome presenting with features of Sjögren’s disease: a case-based review of VEXAS and autoimmune disease overlap

Abstract

VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome) is an adult-onset autoinflammatory disorder caused by somatic mutations in the UBA1 gene. While its clinical spectrum is expanding, the overlap with autoimmune diseases remains poorly characterized. We present the first reported case of VEXAS featuring overlap with Sjögren’s disease. An 86-year-old man with myelodysplastic syndrome developed recurrent fevers, a skin rash, chondritis, bilateral anterior uveitis, acute kidney injury, and macrocytic anemia. He had chronic xerostomia, high titer SSA antibodies, and a positive rheumatoid factor, suggestive of Sjögren’s disease. Genetic testing confirmed a UBA1 p.Met41Thr mutation. Our literature review revealed VEXAS co-occurring with various autoimmune conditions, including vasculitides, systemic lupus erythematosus, rheumatoid arthritis, spondyloarthritis, myositis, and autoimmune blistering diseases. Sjögren’s disease has not previously been associated with VEXAS. This report adds to the growing evidence of VEXAS-associated autoimmunity. Recognition of such overlap may influence early diagnostic consideration and genetic testing in elderly patients with autoimmune features and cytopenias. Further studies are needed to discern whether these autoimmune features represent independent disease processes or manifestations of VEXAS itself.
Title
VEXAS syndrome presenting with features of Sjögren’s disease: a case-based review of VEXAS and autoimmune disease overlap
Authors
Marwin Groener
Hailey Baker
Abhijeet Danve
Publication date
05-11-2025
Publisher
Springer International Publishing
Published in
Clinical Rheumatology
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-025-07773-6
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Health+ IME
Learn more
Image Credits
Histology of patient with VEXAS syndrome presenting with Sjogren's features/© 2025, Marwin Groener et al, under exclusive licence to International League of Associations for Rheumatology (ILAR), Clin Rheumatol, Lupus concept/© (M) Vitalii But / stock.adobe.com / Generated with AI, Aplastic Anemia/© Springer Healthcare IME